The value of a model to consider the cost-effectiveness of interventions for the treatment of major depressive disorder in Canada

[See related article at www.cmaj.ca/lookup/doi/10.1503/cmaj.221785][1] KEY POINTS Major depressive disorder (MDD) remains a leading cause of disability in Canada, and increasingly so, despite considerable advances in treatment options and the availability of antidepressant medications.[1][2] Only